Yuki Katsuya

11PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 08, 2026
Autologous Glypican-3-Targeted, Armored CAR T Cells in Patients with Advanced Solid Tumors: A Phase 1 Dose-Escalation Study of TAK-102.

|May 18, 2026
Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.

|Jan 04, 2026
Prospective monitoring of plasma abemaciclib in breast cancer patients: associations with age and adverse events.

Keisuke Ikegami, Reiko Ando Makihara, Yuki Katsuya

|Dec 29, 2025
Humoral and T-cell immune responses to coronavirus disease 2019 vaccines in patients with hematological malignancies.

Haruhi Makino, Suguru Fukuhara, Keiji Okinaka

|Jun 26, 2025
Next-Generation CAR-T and TCR-T Cell Therapies for Solid Tumors: Innovations, Challenges, and Global Development Trends.

Tomomi Sanomachi, Yuki Katsuya, Tetsuya Nakatsura

|Jan 20, 2025
A Phase I, First-In-Human Study of CBA-1205, an Anti-DLK1 Monoclonal Antibody, in Patients With Advanced Solid Tumors.

Yuki Katsuya, Masafumi Ikeda, Takafumi Koyama

Pageof 2

Frequent Collaborators

7 joint publications

Takafumi Koyama

6 joint publications

Noboru Yamamoto

5 joint publications

Jun Sato

4 joint publications

Shunsuke Kondo